Vanda Pharmaceuticals

$16.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+0.86%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell VNDA and other stocks, options, and ETFs commission-free!

About VNDA

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder.

CEO
Mihael Hristos Polymeropoulos
Employees
292
Headquarters
Washington, District of Columbia
Founded
2002
Market Cap
941.95M
Price-Earnings Ratio
37.65
Dividend Yield
—
Average Volume
501.85K
High Today
$16.74
Low Today
$16.42
Open Price
$16.42
Volume
266.36K
52 Week High
$20.51
52 Week Low
$9.00

VNDA Earnings

$0.00
$0.08
$0.15
$0.23
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 5, After Hours

You May Also Like

WGO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure